Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2
- PMID: 2742504
- DOI: 10.1007/BF00334637
Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2
Abstract
HI-6 is presently considered the most potent oxime antidote against soman poisoning in mice, rats, dogs and monkeys. However, it is still an open question whether efficiency of HI-6, observed in experimental animals, can be extrapolated to soman intoxicated humans. In this paper efficiency of HI-6 and possible mechanisms of action were compared in rat and human fresh muscle preparations. In rat muscle, about 50% of control AChE activity could be recovered by both therapeutic (5 min after soman) and prophylactic (5 min before soman) application of HI-6. On the other hand, in human muscle therapeutic treatment restored only 5%, while prophylactic application of HI-6 again resulted in about 50% recovery of control AChE activity. As revealed by comparison of the prophylactic effects of HI-6 and the non-oxime bispyridinium compound SAD-128, competitive inhibition of AChE plays a minor role as a protective mechanism. Immediate reactivation of rapidly aging human AChE must therefore be instituted for successful protective treatment by HI-6. Retardation of aging, a direct effect of SAD-128, was roughly estimated to improve reactivation by HI-6 for about 10% of control AChE activity of the human muscle. PAM-2 proved completely inefficient as a therapeutic and as a prophylactic agent on both rat and human muscle preparations.
Similar articles
-
In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human.Arch Toxicol. 1994;68(10):648-55. doi: 10.1007/BF03208345. Arch Toxicol. 1994. PMID: 7857205
-
Evaluation of several oximes as reactivators of unaged soman-inhibited whole blood acetylcholinesterase in rabbits.Biochem Pharmacol. 1990 Dec 15;40(12):2677-82. doi: 10.1016/0006-2952(90)90586-a. Biochem Pharmacol. 1990. PMID: 2260991
-
Prophylactic potential of memantine against soman poisoning in rats.Toxicology. 2019 Mar 15;416:62-74. doi: 10.1016/j.tox.2019.01.012. Epub 2019 Jan 22. Toxicology. 2019. PMID: 30682440
-
The influence of soman simulator on reactivation by HI-6 of soman-inhibited acetylcholinesterase in preparations of rat and human skeletal muscle.Biochem Pharmacol. 1993 Jan 26;45(2):499-508. doi: 10.1016/0006-2952(93)90088-e. Biochem Pharmacol. 1993. PMID: 8382066
-
Role of edrophonium in prevention of the re-inhibition of acetylcholinesterase by phosphorylated oxime.Chem Biol Interact. 1999 May 14;119-120:129-35. doi: 10.1016/s0009-2797(99)00021-6. Chem Biol Interact. 1999. PMID: 10421446 Review.
Cited by
-
Mitigating organophosphate nerve agent, soman (GD), induced long-term neurotoxicity: Saracatinib, a Src Tyrosine Kinase inhibitor, as a potential countermeasure.J Neuroinflammation. 2025 Aug 5;22(1):199. doi: 10.1186/s12974-025-03520-5. J Neuroinflammation. 2025. PMID: 40764938 Free PMC article.
-
In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human.Arch Toxicol. 1994;68(10):648-55. doi: 10.1007/BF03208345. Arch Toxicol. 1994. PMID: 7857205
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous